Antimalarial Drugs and Molecules Inhibiting Hemozoin Formation

Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

Volumn , Issue , 2011, Pages 205-234

  Bandyopadhyay, Uday ^a   Dey, Sumanta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Antimalarials; Food vacuole; Heme toxicity; Hemozoin; Oxidative stress; Plasmodium; Quinolines

Indexed keywords

EID: 84858767754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527633883.ch11     Document Type: Chapter

References (130)

1. Breman, J.G., Alilio, M.S., and Mills, A. (2004) Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg., 71, 1-15.
2. Ndugwa, R.P., Ramroth, H., Muller, O., Jasseh, M., Sie, A., Kouyate, B., Greenwood, B. et al. (2008) Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns. Malar. J., 7, 15.
3. Miller, L.H., Baruch, D.I., Marsh, K., and Doumbo, O.K. (2002) The pathogenic basis of malaria. Nature, 415, 673-679.
4. Kumar, S. and Bandyopadhyay, U. (2005) Free heme toxicity and its detoxification systems in human. Toxicol. Lett., 157, 175-188.
5. Gluzman, I.Y., Francis, S.E., Oksman, A., Smith, C.E., Duffin, K.L., and Goldberg, D.E. (1994) Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest., 93, 1602-1608.
6. Vander Jagt, D.L., Hunsaker, L.A., and Campos, N.M. (1987) Comparison of proteases from chloroquinesensitive and chloroquineresistant strains of Plasmodium falciparum. Biochem. Pharmacol., 36, 3285-3291.
7. Campanale, N., Nickel, C., Daubenberger, C.A., Wehlan, D.A., Gorman, J.J., Klonis, N., Becker, K. et al. (2003) Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum. J. Biol. Chem., 278, 27354-27361.
8. Famin, O. and Ginsburg, H. (2003) The treatment of Plasmodium falciparuminfected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase. Parasite, 10, 39-50.
9. Chou, A.C. and Fitch, C.D. (1981) Mechanism of hemolysis induced by ferriprotoporphyrin IX. J. Clin. Invest., 68, 672-677.
10. Solar, I., Dulitzky, J., and Shaklai, N. (1990) Hemin-promoted peroxidationof red cell cytoskeletal proteins. Arch. Biochem. Biophys., 283, 81-89.
11. Atamna, H. and Ginsburg, H. (1993) Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol. Biochem. Parasitol., 61, 231-241.
12. Becker, K., Tilley, L., Vennerstrom, J.L., Roberts, D., Rogerson, S., and Ginsburg, H. (2004) Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol., 34, 163-189.
13. Klouche, K., Morena, M., Canaud, B., Descomps, B., Beraud, J.J., and Cristol, J.P. (2004) Mechanism of in vitro hemeinduced LDL oxidation: effects of antioxidants. Eur. J. Clin. Invest., 34, 619-625.
14. Golenser, J., Marva, E., Har-El, R., and Chevion, M. (1991) Induction of oxidant stress by iron available in advanced forms of Plasmodium falciparum. Free Radic. Res. Commun., 12-13 (Pt 2), 639-643.
15. Egan, T.J. (2008) Haemozoin formation. Mol. Biochem. Parasitol., 157, 127-136.
16. Ginsburg, H., Famin, O., Zhang, J., and Krugliak, M. (1998) Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem. Pharmacol., 56, 1305-1313.
17. Kumar, S., Guha, M., Choubey, V., Maity, P., and Bandyopadhyay, U. (2007) Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life Sci., 80, 813-828.
18. Foley, M. and Tilley, L. (1998) Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther., 79, 55-87.
19. Homewood, C.A., Warhurst, D.C., Peters, W., and Baggaley, V.C. (1972) Lysosomes, pH and the anti-malarial action of chloroquine. Nature, 235, 50-52.
20. Ginsburg, H., Nissani, E., and Krugliak, M. (1989) Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochem. Pharmacol., 38, 2645-2654.
21. Fitch, C.D., Yunis, N.G., Chevli, R., and Gonzalez, Y. (1974) High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei. J. Clin. Invest., 54, 24-33.
22. Hawley, S.R., Bray, P.G., Park, B.K., and Ward, S.A. (1996) Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol. Biochem. Parasitol., 80, 15-25.
23. Krogstad, D.J., Schlesinger, P.H., and Gluzman, I.Y. (1985) Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol., 101, 2302-2309.
24. Krogstad, D.J. and Schlesinger, P.H. (1987) The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. Am. J. Trop. Med. Hyg., 36, 213-220.
25. Ferrari, V. and Cutler, D.J. (1991) Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains. Biochem. Pharmacol., 42 (Suppl), S167-S179.
26. + exchanger determines chloroquine uptake in Plasmodium falciparum. J. Cell Biol., 140, 335-345.
27. Saliba, K.J. and Kirk, K. (1999) pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a v-type h(+)-atpase. J. Biol. Chem., 274, 33213-33219.
28. Chou, A.C., Chevli, R., and Fitch, C.D. (1980) Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry, 19, 1543-1549.
29. Bray, P.G., Janneh, O., Raynes, K.J., Mungthin, M., Ginsburg, H., and Ward, S.A. (1999) Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity inPlasmodium falciparum. J. Cell Biol., 145, 363-376.
30. Moreau, S., Perly, B., and Biguet, J. (1982) Interaction of chloroquine with ferriprotophorphyrin IX. Nuclear magnetic resonance study. Biochimie, 64, 1015-1025.
31. Adams, P.A., Berman, P.A., Egan, T.J., Marsh, P.J., and Silver, J. (1996) The iron environment in heme and hemeantimalarial complexes of pharmacological interest. J. Inorg. Biochem., 63, 69-77.
32. Egan, T.J.,Mavuso,W.W., Ross, D.C., and Marques, H.M. (1997) Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. J. Inorg. Biochem., 68, 137-145.
33. Cohen, S.N., Phifer, K.O., and Yielding, K.L. (1964) Complex formation between chloroquine and ferrihaemic acid in vitro, and its effect on the antimalarial action of chloroquine. Nature, 202, 805-806.
34. Leed, A., DuBay, K., Ursos, L.M., Sears, D., De Dios, A.C., and Roepe, P.D. (2002) Solution structures of antimalarial drug-heme complexes. Biochemistry, 41, 10245-10255.
35. Webster, G.T., McNaughton, D., and Wood, B.R. (2009) Aggregated enhanced Raman scattering in Fe(III)PPIX solutions: the effects of concentration and chloroquine on excitonic interactions. J. Phys. Chem. B., 113, 6910-6916.
36. Dorn, A., Vippagunta, S.R., Matile, H., Jaquet, C., Vennerstrom, J.L., and Ridley, R.G. (1998) An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol., 55, 727-736.
37. Fitch, C.D. (1986) Antimalarial schizontocides: ferriprotoporphyrin IX interaction hypothesis. Parasitol. Today, 2, 330-331.
38. Macomber, P.B., O'Brien, R.L., andHahn, F.E. (1966) Chloroquine: physiological basis of drug resistance in Plasmodium berghei. Science, 152, 1374-1375.
39. Pandey, A.V. and Tekwani, B.L. (1997) Depolymerization of malarial hemozoin: a novel reaction initiated by blood schizontocidal antimalarials. FEBS Lett., 402, 236-240.
40. Hofheinz, W. and Merkli, B. (1984) Quinine and quinine analogues, in Antimalarial Drugs II (eds.W. Peters and W.H.G. Richards), Springer Verlag, Berlin.
41. Sweeney, T.R. (1984) Drugs with quininelike action, Antimalarial Drugs II: Current Antimalarials and New Drug Developments, Springer-Verlag, Berlin, Heidelberg, pp. 267-313.
42. Kaschula, C.H., Egan, T.J., Hunter, R., Basilico, N., Parapini, S., Taramelli, D., Pasini, E. et al. (2002) Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J. Med. Chem., 45, 3531-3539.
43. Egan, T.J. (2001) Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials. Mini Rev. Med. Chem., 1, 113-123.
44. De, D., Krogstad, F.M., Byers, L.D., and Krogstad, D.J. (1998) Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. J. Med. Chem., 41, 4918-4926.
45. O'Neill, P.M., Bray, P.G., Hawley, S.R., Ward, S.A., and Park, B.K. (1998) 4-Aminoquinolines-past, present, and future: a chemical perspective. Pharmacol. Ther., 77, 29-58.
46. De, D., Krogstad, F.M., Cogswell, F.B., and Krogstad, D.J. (1996) Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg., 55, 579-583.
47. Ridley, R.G., Hofheinz, W., Matile, H., Jaquet, C., Dorn, A., Masciadri, R., Jolidon, S. et al. (1996) 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother., 40, 1846-1854.
48. Hofheinz, W. and Masciadri, R. (1999) Quinoline derivatives for treating malaria. US Patent 5948791.
49. Churchill, F.C., Patchen, L.C., Campbell, C.C., Schwartz, I.K., Nguyen-Dinh, P., and Dickinson, C.M. (1985) Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci., 36, 53-62.
50. Peters,W. and Robinson, B.L. (1992) The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Ann. Trop. Med. Parasitol., 86, 455-465.
51. Hawley, S.R., Bray, P.G., O'Neill, P.M., Naisbitt, D.J., Park, B.K., and Ward, S.A. (1996) Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Antimicrob. Agents Chemother., 40, 2345-2349.
52. O'Neill, P.M., Willock, D.J.,Hawley, S.R., Bray, P.G., Storr, R.C., Ward, S.A., and Park, B.K. (1997) Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues. J. Med. Chem., 40, 437-448.
53. Bray, P.G., Hawley, S.R., Mungthin, M., and Ward, S.A. (1996) Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol., 50, 1559-1566.
54. Neftel, K.A., Woodtly, W., Schmid, M., Frick, P.G., and Fehr, J. (1986) Amodiaquine induced agranulocytosis and liver damage. Br. Med. J. (Clin. Res. Ed.): 292, 721-723.
55. O'Neill, P.M., Mukhtar, A., Stocks, P.A., Randle, L.E., Hindley, S., Ward, S.A., Storr, R.C. et al. (2003) Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. J. Med. Chem., 46, 4933-4945.
56. Paunescu, E., Susplugas, S., Boll, E., Varga, R., Mouray, E., Grosu, I., Grellier, P. et al. (2009) Replacement of the 40- hydroxy group of amodiaquine and amopyroquine by aromatic and aliphatic substituents: synthesis and antimalarial activity. ChemMedChem, 4, 549-561.
57. Chang, C., Lin-Hua, T., and Jantanavivat, C. (1992) Studies on a new antimalarial compound: pyronaridine. Trans. R. Soc. Trop. Med. Hyg., 86, 7-10.
58. Fu, S. and Xiao, S.H. (1991) Pyronaridine: A new antimalarial drug. Parasitol. Today, 7, 310-313.
59. Kotecka, B.M., Barlin, G.B., Edstein, M.D., and Rieckmann, K.H. (1997) New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine. Antimicrob. Agents Chemother., 41, 1369-1374.
60. Egan, T.J., Hunter, R., Kaschula, C.H., Marques, H.M., Misplon, A., and Walden, J. (2000) Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinolinehematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity. J.Med. Chem., 43, 283-291.
61. McChesney, E.W. and Fitch, C.D. (1984) 4-Aminoquinolines, in Antimalarial Drugs II: Current Antimalarials and New Drug Developments (eds W. Peters and W.H.G. Richards), Springer-Verlag, Berlin, Heidelberg, pp. 30-60.
62. Karle, J.M. and Karle, I.L. (1991) Crystal structure and molecular structure of mefloquine methylsulfonate monohydrate: implications for a malaria receptor. Antimicrob. Agents Chemother., 35, 2238-2245.
63. Sowunmi, A., Salako, L.A., Oduola, A.M., Walker, O., Akindele, J.A., and Ogundahunsi, O.A. (1993) Neuropsychiatric side effects of mefloquine in Africans. Trans. R. Soc. Trop. Med. Hyg., 87, 462-463.
64. Bouchaud, O., Imbert, P., Touze, J.E., Dodoo, A.N., Danis, M., and Legros, F. (2009) Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base. Malar. J., 8, 289.
65. van Vugt, M., Ezzet, F., Nosten, F., Gathmann, I., Wilairatana, P., Looareesuwan, S., and White, N.J. (1999) No evidence of cardiotoxicity during antimalarial treatment with artemetherlumefantrine. Am. J. Trop. Med. Hyg., 61, 964-967.
66. Sparatore, A., Basilico, N., Casagrande, M., Parapini, S., Taramelli, D., Brun, R., Wittlin, S. et al. (2008) Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinoline. Bioorg. Med. Chem. Lett., 18, 3737-3740.
67. Sunduru, N., Srivastava, K., Rajakumar, S., Puri, S.K., Saxena, J.K., and Chauhan, P.M. (2009) Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials. Bioorg. Med. Chem. Lett., 19, 2570-2573.
68. Sunduru, N., Nishi, Palne, S., Chauhan, P.M., and Gupta, S. (2009) Synthesis and antileishmanial activity of novel 2,4,6- trisubstituted pyrimidines and 1,3,5- triazines. Eur. J. Med. Chem., 44, 2473-2481.
69. Li, Y.T., Hu, Y.G., Huang, H.Z., Zhu, D.Q., Huang, W.J., Wu, D.L., and Qian, Y.L. (1981) Hydroxypiperaquine phosphate in treatment of falciparum malaria. Chin. Med. J. (Engl.), 94, 301-302.
70. Vennerstrom, J.L., Ellis, W.Y., Ager, A.L. Jr, Andersen, S.L., Gerena, L., and Milhous,W.K. (1992) Bisquinolines. 1.N, N-bis(7-chloroquinolin-4-yl) alkanediamines with potential against chloroquine-resistant malaria. J. Med. Chem., 35, 2129-2134.
71. Raynes, K. (1999) Bisquinoline antimalarials: their role in malaria chemotherapy. Int. J. Parasitol., 29, 367-379.
72. Le Bras, J., Deloron, P., and Charmot, G. (1983) Dichlorquinazine (alpha 4-aminoquinoline) effective in vitro against chloroquine-resistant Plasmodium falciparum. Lancet, 1, 73-74.
73. Chen, L. (1991) Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chin. Med. J. (Engl.), 104, 161-163.
74. Davis, T.M., Hung, T.Y., Sim, I.K., Karunajeewa, H.A., and Ilett, K.F. (2005) Piperaquine: a resurgent antimalarial drug. Drugs, 65, 75-87.
75. Ridley, R.G.,Matile, H., Jaquet, C., Dorn, A., Hofheinz, W., Leupin, W., Masciadri, R. et al. (1997) Antimalarial activity of the bisquinoline trans-N1,N2-bis (7- chloroquinolin-4-yl)cyclohexane-1,2- diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob. Agents Chemother., 41, 677-686.
76. Raynes, K., Foley, M., Tilley, L., and Deady, L.W. (1996) Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation. Biochem. Pharmacol., 52, 551-559.
77. Winter, R.W., Ignatushchenko, M., Ogundahunsi, O.A., Cornell, K.A., Oduola, A.M.,Hinrichs, D.J., and Riscoe, M.K. (1997) Potentiation of an antimalarial oxidant drug. Antimicrob. Agents Chemother., 41, 1449-1454.
78. Ignatushchenko, M.V., Winter, R.W., Bachinger, H.P., Hinrichs, D.J., and Riscoe, M.K. (1997) Xanthones as antimalarial agents; studies of a possible mode of action. FEBS Lett., 409, 67-73.
79. Xu Kelly, J., Winter, R., Riscoe, M., and Peyton, D.H. (2001) A spectroscopic investigation of the binding interactions between 4,5-dihydroxyxanthone and heme. J. Inorg. Biochem., 86, 617-625.
80. Fotie, J., Nkengfack, A.E., Rukunga, G., Tolo, F., Peter, M.G., Heydenreich, M., and Fomum, Z.T. (2003) In-vivo antimalarial activity of some oxygenated xanthones. Ann. Trop. Med. Parasitol., 97, 683-688.
81. Ignatushchenko, M.V., Winter, R.W., and Riscoe, M. (2000) Xanthones as antimalarial agents: stage specificity. Am. J. Trop. Med. Hyg., 62, 77-81.
82. Hay, A.E., Helesbeux, J.J., Duval, O., Labaied, M., Grellier, P., and Richomme, P. (2004) Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii. Life Sci., 75, 3077-3085.
83. Kelly, J.X., Winter, R., Peyton, D.H., Hinrichs, D.J., and Riscoe, M. (2002) Optimization of xanthones for antimalarial activity: the 3,6-bis-omegadiethylaminoalkoxyxanthone series. Antimicrob. Agents Chemother., 46, 144-150.
84. Angerhofer, C.K., Pezzuto, J.M., Konig, G.M., Wright, A.D., and Sticher, O. (1992) Antimalarial activity of sesquiterpenes from the marine sponge Acanthella klethra. J. Nat. Prod., 55, 1787-1789.
85. Wright, A.D., Wang, H., Gurrath, M., Konig, G.M., Kocak, G., Neumann, G., Loria, P. et al. (2001) Inhibition of heme detoxification processes underlies the antimalarial activity of terpene isonitrile compounds from marine sponges. J. Med. Chem., 44, 873-885.
86. Schwarz, O., Brun, R., Bats, J.W., and Schmalz, H.-G. (2002) Synthesis and biological evaluation of new antimalarial isonitriles related to marine diterpenoids. Tetrahedron Lett., 43, 1009-1013.
87. Singh, C., Srivastav, N.C., and Puri, S.K. (2002) In vivo active antimalarial isonitriles. Bioorg. Med. Chem. Lett., 12, 2277-2279.
88. White, R.D., Keaney, G.F., Slown, C.D., and Wood, J.L. (2004) Total synthesis of (+/-)-kalihinol C. Org. Lett., 6, 1123-1126.
89. Chavalitshewinkoon, P., Wilairat, P., Gamage, S., Denny, W., Figgitt, D., and Ralph, R. (1993) Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquineresistant Plasmodium falciparum in vitro. Antimicrob. Agents Chemother., 37, 403-406.
90. Santelli-Rouvier, C., Pradines, B., Berthelot, M., Parzy, D., and Barbe, J. (2004) Arylsulfonyl acridinyl derivatives acting on Plasmodium falciparum. Eur. J. Med. Chem., 39, 735-744.
91. Auparakkitanon, S. and Wilairat, P. (2000) Cleavage of DNA induced by 9- anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum. Biochem. Biophys. Res. Commun., 269, 406-409.
92. Ciesielska, E., Pastwa, E., and Szmigiero, L. (1997) Inhibition of mammalian topoisomerase I by 1-nitro-9- aminoacridines. Dependence on thiol activation.Acta Biochim. Pol., 44, 775-780.
93. Egan, T.J., Mavuso, W.W., and Ncokazi, K.K. (2001) The mechanism of betahematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes. Biochemistry, 40, 204-213.
94. Auparakkitanon, S., Noonpakdee, W., Ralph, R.K., Denny,W.A., and Wilairat, P. (2003) Antimalarial 9-anilinoacridine compounds directed at hematin. Antimicrob. Agents Chemother., 47, 3708-3712.
95. Gamage, S.A., Tepsiri, N., Wilairat, P., Wojcik, S.J., Figgitt, D.P., Ralph, R.K., and Denny, W.A. (1994) Synthesis and in vitro evaluation of 9-anilino-3,6- diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. J. Med. Chem., 37, 1486-1494.
96. Guetzoyan, L., Yu, X.M., Ramiandrasoa, F., Pethe, S., Rogier, C., Pradines, B., Cresteil, T. et al. (2009) Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin. Bioorg. Med. Chem., 17, 8032-8039.
97. Kelly, J.X., Smilkstein, M.J., Brun, R., Wittlin, S., Cooper, R.A., Lane, K.D., Janowsky, A. et al. (2009) Discovery of dual function acridones as a new antimalarial chemotype. Nature, 459, 270-273.
98. Chong, C.R. and Sullivan, D.J. Jr (2003) Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem. Pharmacol., 66, 2201-2212.
99. Huy, N.T., Kamei, K., Yamamoto, T., Kondo, Y., Kanaori, K., Takano, R., Tajima, K. et al. (2002) Clotrimazole binds to heme and enhances hemedependent hemolysis: proposed antimalarial mechanism of clotrimazole. J. Biol. Chem., 277, 4152-4158.
100. Huy, N.T., Kamei, K., Kondo, Y., Serada, S., Kanaori, K., Takano, R., Tajima, K. et al. (2002) Effect of antifungal azoles on the heme detoxification system of malarial parasite. J. Biochem., 131, 437-444.
101. Trivedi, V., Chand, P., Srivastava, K., Puri, S.K., Maulik, P.R., and Bandyopadhyay, U. (2005) Clotrimazole inhibits hemoperoxidase of Plasmodiumfalciparum and induces oxidative stress. Proposed antimalarial mechanism of clotrimazole. J. Biol. Chem., 280, 41129-41136.
102. Gemma, S., Campiani, G., Butini, S., Kukreja, G., Joshi, B.P., Persico, M., Catalanotti, B. et al. (2007) Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore. J. Med. Chem., 50, 595-598.
103. Gemma, S., Campiani, G., Butini, S., Kukreja, G., Coccone, S.S., Joshi, B.P., Persico, M. et al. (2008) Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies. J. Med. Chem., 51, 1278-1294.
104. Atamna, H., Krugliak, M., Shalmiev, G., Deharo, E., Pescarmona, G., and Ginsburg, H. (1996) Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochem. Pharmacol., 51, 693-700.
105. Vennerstrom, J.L., Makler, M.T., Angerhofer, C.K., and Williams, J.A. (1995) Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob. Agents Chemother., 39, 2671-2677.
106. Kalkanidis, M., Klonis, N., Tilley, L., and Deady, L.W. (2002) Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin. Biochem. Pharmacol., 63, 833-842.
107. Schirmer, R.H., Coulibaly, B., Stich, A., Scheiwein, M., Merkle, H., Eubel, J., Becker, K. et al. (2003) Methylene blue as an antimalarial agent. Redox Rep., 8, 272-275.
108. Zoungrana, A., Coulibaly, B., Sie, A., Walter-Sack, I., Mockenhaupt, F.P., Kouyate, B., Schirmer, R.H. et al. (2008) Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One, 3, e1630.
109. Coulibaly, B., Zoungrana, A., Mockenhaupt, F.P., Schirmer, R.H., Klose, C., Mansmann, U., Meissner, P.E. et al. (2009) Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One, 4, e5318.
110. Martiney, J.A.,Cerami, A., and Slater, A.F. (1996) Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait. Mol. Med., 2, 236-246.
111. Basilico, N., Monti, D., Olliaro, P., and Taramelli, D. (1997) Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation. FEBS Lett., 409, 297-299.
112. Cole, K.A., Ziegler, J., Evans, C.A., and Wright, D.W. (2000) Metalloporphyrins inhibit beta-hematin (hemozoin) formation. J. Inorg. Biochem., 78, 109-115.
113. Begum, K., Kim, H.S., Kumar, V., Stojiljkovic, I., and Wataya, Y. (2003) In vitro antimalarial activity of metalloporphyrins against Plasmodium falciparum. Parasitol. Res., 90, 221-224.
114. Kumar, S., Guha, M., Choubey, V., Maity, P., Srivastava, K., Puri, S.K., and Bandyopadhyay, U. (2008) Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species. Free Radic. Biol. Med., 44, 602-613.
115. Kumar, S., Das, S.K., Dey, S., Maity, P., Guha, M., Choubey, V., Panda, G. et al. (2008) Antiplasmodial activity of [(aryl) arylsulfanylmethyl]pyridine. Antimicrob. Agents Chemother., 52, 705-715.
116. Werbovetz, K. (2006) Diamidines as antitrypanosomal, antileishmanial and antimalarial agents. Curr. Opin. Invest. Drugs, 7, 147-157.
117. Bray, P.G., Barrett, M.P., Ward, S.A., and de Koning, H.P. (2003) Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol., 19, 232-239.
118. Stead, A.M., Bray, P.G., Edwards, I.G., DeKoning, H.P., Elford, B.C., Stocks,P.A., and Ward, S.A. (2001) Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Mol. Pharmacol., 59, 1298-1306.
119. Goldberg, D.E., Sharma, V., Oksman, A., Gluzman, I.Y., Wellems, T.E., and Piwnica-Worms, D. (1997) Probing the chloroquine resistance locus of Plasmodium falciparum with a novel class of multidentate metal(III) coordination complexes. J. Biol. Chem., 272, 6567-6572.
120. Wiesner, J., Ortmann, R., Jomaa, H., and Schlitzer, M. (2003) New antimalarial drugs. Angew. Chem. Int. Ed. Engl., 42, 5274-5293.
121. Brinner, K.M., Mi Kim, J., Habashita, H., Gluzman, I.Y., Goldberg, D.E., and Ellman, J.A. (2002) Novel and potent anti-malarial agents. Bioorg. Med. Chem., 10, 3649-3661.
122. Agrawal, R., Tripathi, R., Tekwani, B.L., Jain, S.K., Dutta, G.P., and Shukla, O.P. (2002)Haem polymerase as a novel target of antimalarial action of cyproheptadine. Biochem. Pharmacol., 64, 1399-1406.
123. Van Miert, S., Hostyn, S., Maes, B.U., Cimanga, K., Brun, R., Kaiser, M.,Matyus, P. et al. (2005) Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound. J. Nat. Prod., 68, 674-677.
124. El Sayed, I., Van der Veken, P., Steert, K., Dhooghe, L., Hostyn, S., Van Baelen, G., Lemiere, G. et al. (2009) Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives. J. Med. Chem., 52, 2979-2988.
125. Jonckers, T.H., van Miert, S., Cimanga, K., Bailly, C., Colson, P., De Pauw-Gillet, M.C., van den Heuvel, H. et al. (2002) Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J.Med. Chem., 45, 3497-3508.
126. Bringmann, G. and Pokorny, F. (1995) The naphthylisoquinoline alkaloids, in The Alkaloids (ed. G. Cordell), Academic Press, New York, pp. 127-271.
127. Francois, G., Bringmann, G., Dochez, C., Schneider, C., Timperman, G., and Ake Assi, L. (1995) Activities of extracts and naphthylisoquinoline alkaloids from Triphyophyllum peltatum, Ancistrocladus abbreviatus and Ancistrocladus barteri against Plasmodium berghei (Anka strain) in vitro. J. Ethnopharmacol., 46, 115-120.
128. Francois, G., Timperman, G., Eling, W., Assi, L.A., Holenz, J., and Bringmann, G. (1997) Naphthylisoquinoline alkaloids against malaria: evaluation of the curative potentials of dioncophylline C and dioncopeltine A against Plasmodium berghei in vivo. Antimicrob. Agents Chemother., 41, 2533-2539.
129. Schwedhelm, K.F., Horstmann, M., Faber, J.H., Reichert, Y., Bringmann, G., and Faber, C. (2007) The novel antimalarial compound dioncophylline C forms a complex with heme in solution. ChemMedChem, 2, 541-548.
130. Jiang, S., Zeng, Q., Gettayacamin, M., Tungtaeng, A., Wannaying, S., Lim, A., Hansukjariya, P. et al. (2005) Antimalarial activities and therapeutic properties of febrifugine analogs. Antimicrob. Agents Chemother., 49, 1169-1176.